Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol Loaded Nanoparticles in Periodontitis
NCT07397026Phase 1Active, not recruiting
- Start
- Aug 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of resveratrol 1% gel in periodontitis (4 arms). Primary endpoint: Clinical Attachment Level at 3 months. Started Aug 2025; status: active, not recruiting.
02
Drugs
resveratrol 1% gel
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT07397026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07397026.